共 167 条
The expansion and maintenance of antigen-selected CD8+ T cell clones
被引:25
作者:
Fearon, Douglas T.
[1
]
机构:
[1] Univ Cambridge, Wellcome Trust Immunol Unit, Med Res Council Ctr, Cambridge CB2 2QH, England
来源:
ADVANCES IN IMMUNOLOGY, VOL 96
|
2007年
/
96卷
基金:
美国国家卫生研究院;
英国医学研究理事会;
英国惠康基金;
关键词:
D O I:
10.1016/S0065-2776(07)96003-4
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
The biological purpose of the mature, postthymic CD8+ T cell is to respond to microbial antigens with a developmental program of clonal expansion and concomitant differentiation leading to effector cells (T-EFF) that provide antimicrobial defense. Because many microbial infections persist into a chronic phase, this antigen-stimulated developmental program must be capable of continually generating T-EFF, perhaps for the lifetime of the individual. This chapter proposes that the ability of a CD8+ T cell clone to maintain the continual production of T-EFF during periods of persistent antigenic stimulation is based on a program that has two sequential phases of clonal expansion: an initial stage that occurs mainly in the secondary lymphoid tissues and is mediated by ligation of the T cell receptor (TCR) and CD27, and a subsequent, IL-2-dependent phase that occurs predominantly in peripheral, nonlymphoid tissues. The TCR/CD27-dependent phase establishes a nondifferentiating, self-renewing pool of clonally expanding cells, and the IL-2-dependent phase mediates continued clonal expansion that is coupled to the development of T-EFF. The two pools are linked by the process of asymmetrical division within the self-renewing subset so that, at steady state of cellular replication in this TCR/CD27-dependent subset, one daughter cell remains undifferentiated and the other initiates its commitment to IL-2-dependent terminal differentiation. Superimposed on this basic scheme are a shift in the CD8+ T cell response to type I and II interferon (IFN) from anti- to pro-proliferative and transcriptional control of replicative senescence by Bmi-1, Bimp-1, and BCL6/BCL6b. This developmental program ensures that despite the occurrence of cellular senescence antiviral CD8+ T cell clones are maintained for the duration of persistent viral infections.
引用
收藏
页码:103 / 139
页数:37
相关论文